Japan-based Global Specialty Pharmaceutical Company Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto.) (TOKYO:4151) today announced that Masashi Miyamoto, Ph.D. will take the role of ...

TOKYO--(BUSINESS WIRE)--Japan-based Global Specialty Pharmaceutical Company Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto.) (TOKYO:4151) today announced that Masashi Miyamoto ...

Helping Kyowa Kirin transform into a true Japan-based global specialty pharmaceutical company that makes people smile has been one of the greatest privileges of my life, and I am confident that ...

31, 2024 /PRNewswire/ -- Japan-based Global Specialty Pharmaceutical Company Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto) today announced that Masashi Miyamoto, Ph.D. will take the ...

The challenging thing about Australian business isn’t necessarily steadily rising wages bills and energy costs. It isn’t ...

Miyamoto, as Chairman and CEO, will lead discussions on Kyowa Kirin’s direction and overall strategy and maintain key relationships with stakeholders, while Mullick, as President and COO, will oversee ...